1. Puttagunta S, Aronin S, Gupta V, Murray J, Dunne M. Impact of initial inappropriate antibiotic therapy on outcome for uncomplicated urinary tract infection due to fluoroquinolone non-susceptible Enterobacteriaceae [abstract plus poster]. American Society for Microbiology (ASM) MICROBE 2018. Atlanta, GA; 2018.
2. Karlowsky J, Lagacé-Wiens P, Simner P, DeCorby M, Adam H, Walkty A, et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother. 2011;55:3169–75.
3. Dunne MW, Snow K, Mehta R. Failure of empiric treatment of uncomplicated urinary tract infection (UTI) associated with resistant pathogens [abstract no. 4561 plus poster]. American Society for Microbiology (ASM) MICROBE 2019. San Francisco, CA; 2019.
4. Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132:234–50.
5. Puttagunta S, Aronin S, Gupta V, Murray J, Dunne M. Impact of initial inappropriate antibiotic therapy on outcome for uncomplicated urinary tract infection due to antibiotic non-susceptible Enterobacteriaceae [abstract plus poster]. American Society for Microbiology (ASM) MICROBE 2018. Atlanta, GA; 2018.